Combination Immunotherapy for Advanced Melanoma—How to Choose? The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

As pediatric palliative oncology physician-scientists studying communication and decision making in advanced cancer, quality of end-of-life care, and parental bereavement, we have encountered ...

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial ...

Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care WTP in BC prevention trials was the highest for women with known genetic risk and for interventions involving a behavior ...

Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial ...